Disparities in Uptake of 13-valent Pneumococcal Conjugate Vaccine among Older Adults Following Routine Recommendation in the United States

BACKGROUND: In the fall of 2014, the Advisory Committee on Immunization Practices (ACIP) recommended 13-valent pneumococcal conjugate vaccine (PCV13) for all US adults age ≥65 years. Coverage rates are currently unknown. This study estimated overall PCV13 coverage rates in older adults and determine...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, John, Khan, Farid, Curry, Aaron, Snow, Vincenza, Isturiz, Raúl, Swerdlow, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630821/
http://dx.doi.org/10.1093/ofid/ofx163.1197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630821/
http://dx.doi.org/10.1093/ofid/ofx163.1197

Ejemplares similares